Synthesis and Evaluation of GdIII-Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane Antigen

Preclinical Evaluation of 86Y-Labeled Inhibitors of Prostate-Specific Membrane Antigen for Dosimetry Estimates

(2015) S. R. Banerjee et al.   JOURNAL OF NUCLEAR MEDICINE

PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer

(2015) Brian Wan-Chi Tse et al.   Nanomedicine

Evaluation of a PSMA-targeted BNF nanoparticle construct

(2015) Babak Behnam Azad et al.   Nanoscale

On the Fate of MRI Gd-Based Contrast Agents in Cells. Evidence for Extensive Degradation of Linear Complexes upon Endosomal Internalization

(2013) Enza Di Gregorio et al.   ANALYTICAL CHEMISTRY

Gd-based Macromolecules and Nanoparticles as Magnetic Resonance Contrast Agents for Molecular Imaging

(2013) Ching-Hui Huang et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

PSMA-Targeted Theranostic Nanoplex for Prostate Cancer Therapy

(2012) Zhihang Chen et al.   ACS Nano

Synthesis and Evaluation of a Peptide Targeted Small Molecular Gd-DOTA Monoamide Conjugate for MR Molecular Imaging of Prostate Cancer

(2012) Xueming Wu et al.   BIOCONJUGATE CHEMISTRY

High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity

(2012) Michael C Haffner et al.   MODERN PATHOLOGY

Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen

(2011) Sangeeta Ray Banerjee et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

In Vivo Magnetic Resonance Imaging of the Estrogen Receptor in an Orthotopic Model of Human Breast Cancer

(2011) A. Pais et al.   CANCER RESEARCH

123I-MIP-1072, a Small-Molecule Inhibitor of Prostate-Specific Membrane Antigen, Is Effective at Monitoring Tumor Response to Taxane Therapy

(2011) S. M. Hillier et al.   JOURNAL OF NUCLEAR MEDICINE

A Modular System for the Synthesis of Multiplexed Magnetic Resonance Probes

(2011) Daniel J. Mastarone et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen

(2011) M. J. Evans et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA)

(2010) Sachin S. Chandran et al.   CANCER BIOLOGY & THERAPY

Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C

(2010) Thomas Frenzel et al.   INVESTIGATIVE RADIOLOGY

68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer

(2010) Sangeeta Ray Banerjee et al.   JOURNAL OF MEDICINAL CHEMISTRY

MRI Detection of VEGFR2in VivoUsing a Low Molecular Weight Peptoid−(Gd)8-Dendron for Targeting

(2010) Luis M. De León-Rodríguez et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Bioresponsive, Cell-Penetrating, and Multimeric MR Contrast Agents

(2009) Jody L. Major et al.   ACCOUNTS OF CHEMICAL RESEARCH

Protein-Targeted Gadolinium-Based Magnetic Resonance Imaging (MRI) Contrast Agents: Design and Mechanism of Action

(2009) Peter Caravan   ACCOUNTS OF CHEMICAL RESEARCH

Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1contrast agents

(2009) Peter Caravan et al.   Contrast Media & Molecular Imaging

Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)

(2008) Sangeeta R. Banerjee et al.   JOURNAL OF MEDICINAL CHEMISTRY

The detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomain

(2008) Kenjiro Hanaoka et al.   MAGNETIC RESONANCE IMAGING